| Authors: |
Pallareti L; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Rath TF; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Trapkov B; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Tsonkov T; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Nielsen AT; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Harpsøe K; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Gentry PR; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Bräuner-Osborne H; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Gloriam DE; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark. Electronic address: david.gloriam@sund.ku.dk., Foster SR; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark; Monash Biomedicine Discovery Institute, Cardiovascular Disease Program, Department of Pharmacology, Monash University, Clayton, VIC, Australia; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. Electronic address: simon.foster@qimrberghofer.edu.au. |
